Dangerous Clutter: FDA Takes On Errors Caused By Drug Labels, Packaging
Executive Summary
Reducing the amount of unnecessary information on drug labels is one of several key ways to stop dangerous medication errors, a panel that is helping FDA develop guidance on the subject agreed
You may also be interested in...
Container Labels Expose Two Sides Of Color: Attention Getter, Lure To Medication Errors
FDA draft guidance lays out how sponsors can design drug container labels and carton labeling to avoid drug use mistakes by making the most important information accessible to health care providers and patients.
PhRMA Seeks Repeal Of Brand Name Review Rule Until A Benefit Is Shown
The pharmaceutical industry wants FDA to prove its proprietary name review program is worth the effort.
PhRMA Seeks Repeal Of Brand Name Review Rule Until A Benefit Is Shown
The pharmaceutical industry wants FDA to prove its proprietary name review program is worth the effort.